A new AI model is much better than doctors at identifying patients likely to experience cardiac arrest.

The linchpin is the system’s ability to analyze long-underused heart imaging, alongside a full spectrum of medical records, to reveal previously hidden information about a patient’s heart health.

A collaborative multidisciplinary team of researchers from the Perelman School of Medicine and New York University has developed a miniature chip that could transform how blood cancer treatments are tested and tailored for patients. “This device addresses a significant gap in preclinical research, offering an advanced tool for studying CAR T cell therapy’s dynamic and multifaceted responses to leukemia,” says Saba Ghassemi of the Perelman School of Medicine at the Unviersity of Pennsylvania.